Glucagon signals your liver to release stored glucose and mobilize fat stores for energy
Efficacy and safety of once-weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea: A 52-week open-label, randomized phase III trial
Eating slowly, staying physically active, getting enough sleep, managing stress, and choosing minimally processed foods more often can all complement a GLP-1-friendly diet and support long-term GLP-1 weight loss
The Patient Does Not Meet the Plans Criteria Insurance requirements may be more restrictive than the medications FDA-approved criteria
Hypoglycaemia risk is generally low with GLP-1 agonists alone but may be elevated when combined with insulin or sulfonylureas, particularly in patients with poor nutritional status or irregular eating patterns
In this review we describe the available evidence in detail and present a rational practical guidance for the optimum clinical use of this combination in this patient population
